« Previous
Next »
Titles
- Postmarketing adverse event reporting for medical products and dietary supplements during a pandemic1
- Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates1
- Premarket tobacco product applications for electronic nicotine delivery systems1
- Preparation of food contact notifications for food contact substances in contact with infant formula and/or human milk1
- Prescription Drug User Fee Act waivers, reductions, and refunds for drug and biological products1
- Procedures for meetings of the Medical Devices Advisory Committee: guidance for industry and Food and Drug Administration staff1
- Process to request a review of FDA's decision not to issue certain export certificates for devices: guidance for industry and Food and Drug Administration staff1
- Product labeling for certain ultrasonic surgical aspirator devices: guidance for Industry and Food and Drug Administration staff1
- Product name placement, size, and prominence in promotional labeling and advertisements1
- Providing regulatory submissions for medical devices in electronic format: submissions under Section 745A(b) of the Federal Food, Drug, and Cosmetic Act : guidance for industry and Food and Drug Administration staff1
- Providing regulatory submissions in electronic format--certain human pharmaceutical product applications and related submissions using the eCTD specifications1
- Providing regulatory submissions in electronic format: certain human pharmaceutical product applications and related submissions using the eCTD specifications1
- Public health information technology: HHS has made little progress toward implementing enhanced situational awareness network capabilities : report to Congressional committees1
- Pulling together: administrative and budget consolidation of state long-term care services1